分子応答　片山グループ

2024年

	著書	2	Bacterial Enzyme Assay for Mucin Glycan Degradation Toshihiko Katoh, and Hisashi Ashida Methods Mol Biol. 2024:2763:337-344.doi: 10.1007/978-1-0716-3670-1_28.
		1	Cultivation of Microorganisms in Media Supplemented with Mucin Glycoproteins Hiromi Takada, Takane Katayama, Toshihiko Katoh Methods Mol Biol. 2024:2763:331-335.doi: 10.1007/978-1-0716-3670-1_27.

2023年

	原著論文	11	Preferential sugar utilization by bifidobacterial species Murakami R, Yoshida K, Sakanaka M, Urashima T, Xiao J-Z, Katayama T, and Odamaki T. Microbiome Research Reports 2:31 (2023).
		10	Lactose or milk oligosaccharide: which is significant among mammals. Urashima T, Horiuchi R, Sakanaka M, Katayama T, and Fukuda K. Animal Frontiers 13(3):14–23 (2023)
		9	Identification of Core Yeast Species and Microbe-Microbe Interactions Impacting Larval Growth of Drosophila in the Wild. Mure A, Sugiura Y, Maeda R, Honda K, Sakurai N, Takahashi Y, Watada M,Katoh T , Gotoh A, Gotoh Y, Taniguchi I, Nakamura K, Hayashi T, Katayama T, Uemura T, Hattori Y eLife 90148.1 (2023)
		8	Research overview of L-DOPA production using a bacterial enzyme, tyrosine phenol-lyase. Kumagai H, Katayama T, Koyanagi T, and Suzuki H. Proceedings of the Japan Academy, Series B. 99(3):75-101 (2023)
		7	Comprehensive analysis of metabolites produced by co-cultivation of Bifidobacterium breve MCC1274 with human iPS-derived intestinal epithelial cells. Sen A, NishimuraT, YoshimotoS, Yoshida K, Gotoh A, Katoh T, Yoneda Y, Hashimoto T, Xiao, J.-Z. Katayama T, and Odamaki T.  Frontier in Microbiology 14:1155438 (2023).
		6	GH20 and GH84 β-N-acetylglucosaminidases with different linkage specificities underpin mucin O-glycan breakdown capability of Bifidobacterium bifidum Takada H, Katoh T, Sakanaka M, Odamaki T, and Katayama T.  Journal of Biological Chemistry.* 299(6):104781 (2023).
		5	Substrate recognition mode of a glycoside hydrolase family 42 β-galactosidase from Bifidobacterium longum subspecies infantis (BiBga42A) revealed by crystallographic and mutational analyses. Gotoh A, Hidaka M, Sakurama H, Nishimoto M, Kitaoka M, Sakanaka M , Fushinobu S, and Katayama T. Microbiome Research Reports. 2:20 (2023).
		4	A bacterial sulfoglycosidase highlights mucin O-glycan breakdown in the gut ecosystem Katoh T, Yamada C, Wallace M, Yoshida A, Gotoh A, Arai M, Maeshibu T, Kashima T, Hagenbeek A, Ojima MN, Takada H, Sakanaka M, Shimizu H, Nishiyama K, Ashida H, Hirose J, Suarez-Diez M, Nishiyama M, Kimura I, Stubbs KA, Fushinobu S, and Katayama T. Nature Chemical Biology. 19(6):778-789 (2023)
		3	A fluorogenic probe for core-fucosylated glycan-preferred ENGase. Ishii N, Muto H, Nagata M, Sano K, Sato I, Iino K, Matsuzaki Y, Katoh T, Yamamoto K, Matsuo I. Carbohydrate Research. 523:108724 (2023).
		2	Host metabolic benefits of prebiotic exopolysaccharides produced by Leuconostoc mesenteroides. Miyamoto J, Shimizu H, Hisa K, Matsuzaki C, Inuki S, Ando Y, Nishida A, Izumi A, Yamano M, Ushiroda C, Irie J, Katayama T, Ohno H, Itoh H, Yamamoto K, Kimura I. Gut Microbes. 15(1):2161271 (2023).
		1	An oral WT1 protein vaccine composed of WT1-anchored, genetically engineered Bifidobacterium longum allows for intestinal immunity in mice with acute myeloid leukemia. Nakagawa N, Hashii Y, Kayama H, Okumura R, Nakajima H, Minagawa H, Morimoto S, Fujiki F, Nakata T, Shirakawa T, Katayama T, Takeda K, Tsuboi A, and Ozono K. Cancer Immunology, Immunotherapy* 72(1):39-53 (2023)
	総説	5	【総説：応用糖質科学シンポジウム】Bifidobacterium bifidum由来の硫酸化ムチン糖鎖および血液型抗原分解酵素の構造基盤鹿島騰真, 加藤紀彦, 山田千早, 片山高嶺, 芦田久, 伏信進矢応用糖質科学：日本応用糖質科学会誌　 2023年13巻4号 p.194-202,DOI: https://doi.org/10.5458/bag.13.4_194
		4	腸内細菌のムチン分解機序加藤紀彦、片山高嶺 Glycoforum.2023 Vol.27 (1), A3(2023)., DOI: https://doi.org/10.32285/glycoforum.27A3J
		3	Mucin Decomposition Mechanisms in Gut Bacteria Toshihiko Katoh and Takane Katayama. Glycoforum. 2023 Vol.27 (1), A3(2023).DOI: https://doi.org/10.32285/glycoforum.27A3
		2	ビフィズス菌由来スルフォグリコシダーゼの解析からみえてきた腸内細菌によるムチン糖鎖分解加藤紀彦、片山高嶺消化器病学サイエンス 7(4): 39-42 (2023)
		1	腸内ビフィズス菌による硫酸化ムチン糖鎖の分解メカニズム加藤紀彦、片山高嶺バイオサイエンスとインダストリー 81(6): 528-530 (2023)

2022年

	原著論文	7	Crystal structures of glycoside hydrolase family 136 lacto-N-biosidases from monkey gut- and human adult gut bacteria. Yamada C, Katayama T, Fushinobu S. Bioscience Biotechnology and Biochemistry. 6(4):464-475 (2022).
		6	Human milk oligosaccharide utilization in intestinal bifidobacteria is governed by a global transcriptional regulator NagR. Arzamasov A, Nakajima A, Sakanaka M, Ojima M, Katayama T, Rodionov D, and Osterman A. mSystems 7(5):e00343-22 (2022) https://doi.org/10.1128/msystems.00343-22
		5	Dietary-protein sources modulate host susceptibility to Clostridioides difficile infection through the gut microbiota. Yakabe K, Higashi S, Akiyama M, Mori H, Murakami T, Toyoda A, Sugiyama Y, Kishino S, Okano K, Hirayama A, Gotoh A, Li S, Mori T, Katayama T, Ogawa J, Fukuda S, Hase K, and Kim YG. Cell Reports 40:111332 (2022).
		4	Priority effects shape the structure of infant-type Bifidobacterium communities on human milk oligosaccharides. Ojima MN, Jiang L, Arzamasov AA, Yoshida K, Odamaki T, Xiao J-Z, Nakajima A, Kitaoka M, Hirose J, Urashima T, Katoh T, Gotoh A, van Sinderen D, Rodionov DA, Osterman AL, Sakanaka M, and Katayama T. ISME J 16:2265-2279 (2022)
		3	A simple method that enhances minority species detection in the microbiota: 16S metagenome-DRIP (Deeper Resolution using an Inhibitory Primer) Nakajima A, Yoshida K, Gotoh A, Katoh T, Ojima MN, Sakanaka M, Xiao J-Z, Odamaki T, and Katayama T.* Microbiome Research Reports 1:20 (2022).
		2	(+)-Sesamin, a sesame lignan, is a potent inhibitor of gut bacterial tryptophan indole-lyase that is a key enzyme in chronic kidney disease pathogenesis. Oikawa D, Yamashita S, Takahashi S, Waki T, Kikuchi K, Abe T, Katayama T, and Nakayama T. Biochemical and Biophysical Research Communications 590:158-162 (2022).
		1	Diversification of a fucosyllactose transporter within the genus Bifidobacterium. Ojima MN, Asao Y, Nakajima A, Katoh T, Kitaoka M, Gotoh A, Hirose H, Urashima T, Fukiya S, Yokota A, Abou Hachem, Sakanaka M, and Katayama T. Applied and Environmental Microbiology* 88(2):e0143721 (2022) PMID: 34731055.
	総説	2	Evolution of milk oligosaccharides: Origin and selectivity of the ratio of milk oligosaccharides to lactose among mammals. Urashima T, Katayama T, Sakanaka M, Fukuda K, and Messer M. Biochimica et Biophysica Acta–General Subjects 1866(1):130012 (2022).
		1	Ecological and molecular perspectives on responders and non-responders to probiotics and prebiotics. Ojima MN, Yoshida K, Sakanaka M, Jiang L, Odamaki T, and Katayama T (corresponding author). Current Opinion in Biotechnology 73:108-120.
	著作	1	Milk oligosaccharides in non-bovine milks. In: McSweeney, P.L.H. and McNamara, J.P. (Eds.), Urashima T, Fukuda K, and Katayama T. Encyclopedia of Dairy Sciences, vol. 5. Elsevier, Academic Press, pp. 621–646. DOI: 10.1016/B978-0-12-818766-1.00051-9.ISBN: 9780128187661

2021年

	原著論文	9	Thermococcus sp. KS-1 PPIase as a fusion partner improving soluble production of aromatic amino acid decarboxylase. Koyanagi T, Hara A, Kobayashi K, Habara Y, Nakagawa A, Minami H, Katayama T, and Misawa N. AMB Express 11(1):178 (2021).
		8	Difference between coloration and endogenous abscisic acid accumulation patterns in two red grape cultivars, ‘Aki Queen’ and ‘Ruby Roman’ grape (Vitis labruscana Bailey) berries. Katayama-Ikegami A, Sugiyama Y, Katayama T, Sakamoto A, Shimada R, Miyazaki C, and Gao-Takai M. Horticulture Journal 91(3):312-321 (2021).
		7	Next-generation prebiotic promotes selective growth of bifidobacteria, suppressing Clostridioides difficile. Hirano R, Sakanaka M, Yoshimi K, Sugimoto N, Eguchi S, Yamauchi Y, Nara M, Maeda S, Ami Y, Gotoh A, Katayama T, Iida N, Kato T, Ohno H, Fukiya S, Yokota A, Nishimoto M, Kitaoka M, Nakai H, Kurihara S. Gut Microbes 13(1):1973835. doi: 10.1080/19490976.2021.1973835.
		6	SGLT-1-specific inhibition ameliorates renal failure and alters the gut microbial community in mice with adenine-induced renal failure. Ho H-J, Kikuchi K, Oikawa D, Watanabe S, Kanemitsu Y, Saigusa D, Kujirai R, Ikeda-Ohtsubo W, Ichijo M, Akiyama Y, Aoki Y, Mishima E, Ogata Y, Oikawa Y, Matsuhashi T, Toyohara T, Suzuki C, Suzuki T, Mano N, Kagawa Y, Owada Y, Katayama T, Nakayama T, Tomioka Y, and Abe T. Physiological Report 9:e15092. doi: 10.14814/phy2.15092
		5	Bifidobacterium species associated with breastfeeding produce aromatic lactic acids in the infant gut. Laursen MF, Sakanaka M, von Burg N, Mörbe U, Andersen D, Moll JM, Pekmez CT, Rivollier A, Michaelsen KF, Mølgaard C, Lind MV, Dragsted LO, Katayama T, Frandsen HL, Vinggaard AM, Bahl MI, Brix S, Agace W, Licht TR. and Roager HM. Nature Microbiology 6:1367–1382.
		4	An oral cancer vaccine using a Bifidobactrerium vector suppresses tumor growth in a syngeneic mouse bladder cancer model. Kitagawa K, Tatsumi M, Kato M, Komai S, Doi H, Hashii Y, Katayama T, Fujisawa M, and Shirakawa T. Molecular Therapy – Oncolytics 22:592-603.
		3	Selection of the optimal tyrosine hydroxylation enzyme for (S)-reticuline production in Escherichia coli. Nakagawa A, Nakamura S, Matsumura E, Yashima Y, Takao M, Aburatani S, Yaoi K, Katayama T, and Minami H. Applied Microbiology and Biotechnology 105(13):5433-5447.
		2	Bifidobacterium response to lactulose ingestion in the gut relies on a solute-binding protein-dependent ABC transporter. Yoshida K, Hirano R, Sakai Y, Choi MH, Sakanaka M, Kurihara S, Iino H, Xiao JZ, Katayama T, and Odamaki T. Communications Biology 4(1):541.
		1	Isolation and identification of milk oligosaccharide-degrading bacteria from the intestinal contents of suckling rats. Akazawa H, Tsujikawa Y, Fukuda I, Suzuki Y, Choi M.-H, Katayama T, Mukai T, and Osawa R. Bioscience of Microbiota, Food and Health 40(1):27-32.
	総説	3	ヒトミルクオリゴ糖と腸内細菌－歴史的背景と現状－北岡本光、片山高嶺. Glycoforum 24(6):A16J. DOI:https://doi.org/10.32285/glycoforum.24A16J (non-peer reviewed)
		2	Human milk oligosaccharides and intestinal bacteria: current and past perspectives. Kitaoka M, and Katayama T. Glycoforum 24(6):A16. DOI: https://doi.org/10.32285/glycoforum.24A16 (non-peer reviewed)
		1	Innovative Preparation of Biopharmaceuticals Using Transglycosylation Activity of Microbial Endoglycosidases. Katoh T and Yamamoto K. Journal of Applied Glycoscience 68(1):1-9.
	著作	1	Human milk oligosaccharides and innate immunity. Urashima T, Katayama T, Fukuda K, and Hirabayashi J. pp 389-439 in Comprehensive Glycoscience 2nd Edition (Edited by Joseph J. Barchi Jr.).

2020年

	原著論文	6	Characterization of the recombinant UDP:flavonoid 3-O-galactosyltransferase from Mangifera indica ‘Irwin’ (MiUFGalT3) involved in skin coloring. Katayama-Ikegami A, Byun Z, Okada S, Miyashita M, Katayama T, Sakamoto T, Ichihi A, Shimizu K, and Kanzaki S. Horticulture Journal 89(5):516-524
		5	Butyrate Producing Colonic Clostridiales Metabolise Human Milk Oligosaccharides and Cross Feed on Mucin via Conserved Pathways. Pichler MJ, Yamada C, Shuoker B, Alvarez-Silva C, Gotoh A, Leth ML, Schoof E, Katoh T, Sakanaka M, Katayama T, Jin C, Karlsson NG, Arumugam M, Fushinobu S, and Hachem MA. Nature Communications 11(1):3285.
		4	Bifidobacterium bifidum Suppresses Gut Inflammation Caused by Repeated Antibiotic Disturbance Without Recovering Gut Microbiome Diversity in Mice. Ojima MN, Gotoh A, Takada H, Odamaki T, Xiao J-Z, Katoh T and Katayama T. Frontiers in Microbiology 11:1349.
		3	Sialylated O-Glycans from Hen Egg White Ovomucin are Decomposed by Mucin-degrading Gut Microbes. Takada H, Katoh T (corresponding author), and Katayama T. Journal of Applied Glycoscience 67(2):31-39.
		2	Mitotic cyclin Clb4 is required for the intracellular adaptation to glucose starvation in Saccharomyces cerevisiae. Umekawa M, Shiraishi D, Fuwa M, Sawaguchi K, Mashima Y, Katayama T, and Karita S. (2020). FEBS Letters 594(8):1329-1338
		1	1,6-α-L-Fucosidases from Bifidobacterium longum subsp. infantis ATCC 15697 involved in the degradation of core-fucosylated N-glycan. Ashida H, Fujimoto T, Kurihara S, Nakamura M, Komeno M, Huang Y, Katayama T, Kinoshita T, and Takegawa K. Journal of Applied Glycoscience 67:23-29.
	総説	3	ミルクオリゴ糖・マイクロビオータのグライコミクス. 浦島匡, 片山高嶺, 福田健二. 生化学 92(3):307-322.
		2	Enzymatic Adaptation of Bifidobacterium bifidum to Host Glycans, Viewed from Glycoside Hydrolyases and Carbohydrate-Binding Modules. Katoh T, Ojima MN, Sakanaka M, Ashida H, Gotoh A and Katayama T (corresponding author). Microorganisms 8(4):481.
		1	Varied pathways of infant gut-associated Bifidobacterium to assimilate human milk oligosaccharides: prevalence of the gene set and its correlation with bifidobacteria-rich microbiota formation. Sakanaka M, Gotoh A, Yoshida K, Odamaki T, Koguchi H, Xiao JZ, Kitaoka M, and Katayama T (corresponding author). Nutrients 12(1):7.

2019年

	原著論文	3	Sakanaka M, Hansen ME (equal contribution), Gotoh A, Katoh T, Yoshida K, Odamaki T, Yachi H, Sugiyama Y, Kurihara S, Hirose J, Urashima T, Xiao JZ, Kitaoka M, Fukiya S, Yokota A, Lo Leggio L, Abou Hachem M (corresponding author), and Katayama T (corresponding author). Evolutionary adaptation in fucosyllactose uptake systems supports bifidobacteria-infant symbiosis. Science Advances 5:eaaw7696.
		2	Toda K, Hisata K, Satoh T, Katsumata N, Odamaki T, Mitsuyama E, Katayama T, Kuhara T, Aisaka K, Shimizu T, and Xiao JZ. Neonatal oral fluid as a transmission route for bifidobacteria to the infant gut immediately after birth. Scientific Reports 9:8692.
		1	Shirakawa T, Kitagawa K, Tatsumi M, Gonoi R, Katayama T, Hashii Y, Fujisawa M, and Kadowaki M. Preclinical development of a WT1 oral cancer vaccine using a bacterial vector to treat castration-resistant prostate cancer. Molecular Cancer Therapeutics 18:980-990.
	総説	1	加藤紀彦, 後藤愛那, 尾島望美, 片山高嶺．(2019). 乳児腸管におけるビフィズスフローラ形成には母乳オリゴ糖分解物のクロスフィーディングが関与する？ミルクサイエンス 68(2):117-123.

2018年

	原著論文	4	Gotoh A, Katoh T, Sakanaka M, Ling Y, Yamada C, Asakuma S, Urashima T, Tomabechi Y, Katayama-Ikegami A, Kurihara S, Yamamoto K, Harata G, He F, Hirose J, Kitaoka M, Okuda S and Katayama T. Sharing of human milk oligosaccharides degradants within bifidobacterial communities in faecal cultures supplemented with Bifidobacterium bifidum. Scientific Reports 8, Article number: 13958
		3	Ashida H, Tanigawa K, Kiyohara M, Katoh T, Katayama T, Yamamoto K. Bifunctional properties and characterization of a novel sialidase with esterase activity from Bifidobacterium bifidum. Bioscience, Biotechnology, and Biochemistry 82(11):2030-2039.
		2	Matsumura E, Nakagawa A, Tomabechi Y, Ikushiro S, Sakaki T, Katayama T, Yamamoto K, Kumagai H, Sato F, Minami H. Microbial production of novel sulphated alkaloids for drug discovery. Scientific Reports 8(1):7980.
		1	Higashiyama T, Umekawa M, Nagao M, Katoh T, Ashida H, Yamamoto K. Chemo-enzymatic synthesis of the glucagon containing N-linked oligosaccharide and its characterization. Carbohydrate Research 455:92-96.
	総説	2	Gotoh A, Ojima MN, and Katayama T. Minority species influences microbiota formation: The role of Bifidobacterium with extracellular glycosidases in bifidus flora formation in breast-fed infant guts. Microbial Biotechnology 12:259-264. DOI:10.1111/1751-7915.13366
		1	後藤愛那、加藤紀彦、阪中幹祥、片山高嶺. ヒト母乳オリゴ糖を介した乳児腸管におけるビフィズスフローラ形成機構. 腸内フローラシンポジウム 26 腸内フローラの形成と疾患ー食・栄養・薬がどのようにかかわるのか？－(神谷茂編). p31-41. 医薬出版

2017年

	原著論文	12	Viborg AH, Katayama T, Arakawa T, Abou Hachem M, Lo Leggio Kitaoka M, Svensson B, and Fushinobu S. Discovery of α-L-arabinopyranosidases from human gut microbiome expands the diversity within glycoside hydrolase family 42. Journal of Biological Chemistry 292(51):21092-21101.
		11	Sugiyama Y, Nara M, Sakanaka M, Gotoh A, Kitakata A, Okuda S, Kurihara S. Comprehensive analysis of polyamine transport and biosynthesis in the dominant human gut bacteria: Potential presence of novel polyamine metabolism and transport genes. Int. J. Biochem. Cell Biol. 93:52-61.
		10	Umekawa M, Ujihara M, Nakai D, Takematsu H, Wakayama M. Ecm33 is a novel factor involved in efficient glucose uptake for nutrition-responsive TORC1 signaling in yeast. FEBS Letters 591(22):3721-3729.
		9	Katayama-Ikegami A, Suehiro Y, Katayama T, Jindo K, Itamura H, and Esumi T. Recombinant expression, purification, and characterization of polyphenol oxidase 2 (VvPPO2) from ‘Shine Muscat’ (Vitis labruscana Bailey × Vitis vinifera L.). Bioscience, Biotechnology, and Biochemistry 81(12):2330-2338.
		8	Katoh T (corresponding author), Maeshibu T, Kikkawa K, Gotoh A, Tomabechi Y, Nakamura M, Liao WH, Yamaguchi M, Ashida H, Yamamoto K, and Katayama T. Identification and characterization of a sulfoglycosidase from Bifidobacterium bifidum implicated in mucin glycan utilization. Bioscience, Biotechnology, and Biochemistry 81(10):2018-2027.
		7	Gotoh A, Nara M, Sugiyama Y, Sakanaka M, Yachi H, Kitakata A, Nakagawa A, Minami H, Okuda S, Katoh T, Katayama T, and Kurihara S. Use of Gifu Anaerobic Medium for Culturing 32 Dominant Species of Human Gut Microbes and Its Evaluation Based on Short-chain Fatty Acids Fermentation Profiles. Bioscience, Biotechnology, and Biochemistry 81(10):2009-2017. (BBB論文賞)
		6	Matsuzaki C, Takagaki C, Tomabechi Y, Forsberg LS, Heiss C, Azadi P, Matsumoto K, Katoh T, Hosomi K, Kunisawa J, Yamamoto K, Hisa K. Structural characterization of the immunostimulatory exopolysaccharide produced by Leuconostoc mesenteroides strain NTM048. Carbohydrate Research 448:95-102.
		5	Tomabechi Y, Katoh T, Kunishima M, Inazu T, Yamamoto K. Chemo-enzymatic synthesis of a glycosylated peptide containing a complex N-glycan based on unprotected oligosaccharides by using DMT-MM and Endo-M. Glycoconjugate Journal 34(4):481-487.
		4	Kitagawa K, Oda T, Saito H, Araki A, Gonoi R, Shigemura K, Fujsawa M, Hashii H, Katayama T, and Shirakawa T. Development of oral cancer vaccine using recombinant Bifidobacterium displaying Wilms' tumor 1 protein. Cancer Immunology, Immunotherapy 66(6):787-798.
		3	Yamada C, Gotoh A (Co-first author), Sakanaka M, Hattie M, Stubbs KA, Katayama-Ikegami A, Hirose J, Kurihara S, Arakawa T, Kitaoka M, Okuda S, Katayama T (Co-corresponding author) and Fushinobu S. Molecular Insight into Evolution of Symbiosis between Breast-Fed Infants and a Member of the Human Gut Microbiome Bifidobacterium longum. Cell Chemical Biology 24(4):515-524. →プレスリリース
		2	Kitagawa K, Omoto C, Oda T, Araki A, Saito H, Shigemura K, Katayama T, Hotta H, Shirakawa T. Oral combination vaccine, comprising Bifidobacterium displaying hepatitis C virus nonstructural protein 3 and interferon-α, induces strong cellular immunity specific to nonstructural protein 3 in mice. Viral Immunology 30(3):196-203.
		1	Sugiyama Y, Katoh T (corresponding author), Honda Y, Gotoh A, Ashida H, Kurihara S, Yamamoto K, and Katayama T. Application study of 1,2-α-L-fucosynthase: Introduction of Fucα1-2Gal disaccharide structures on N-glycan, ganglioside, and xyloglucan oligosaccharide. Bioscience, Biotechnology, and Biochemistry 81(2):283-291
	総説	2	後藤愛那、片山高嶺(京大院・生命)、山田千早、伏信進矢(東大院・農生)、櫻間晴子(京都学園大・バイオ). ラクト-N-ビオシダーゼ（LnbX）の機能から考える母乳オリゴ糖を介したビフィズス菌と母乳栄養児の共生・共進化. 酵素工学ニュース第78号.
		1	Mimura Y, Katoh T, Saldova R, O’Flaherty R, Izumi T, Mimura-Kimura Y, Utsunomiya T, Mizukami Y, Yamamoto K, Matsumoto T, Rudd PM. (2017) Glycosylation engineering of therapeutic IgG antibodies: challenges for the safety, functionality and efficacy. Protein & Cell 9(1):47-62.

2016年

	原著論文	15	Yamada C, Sawano K, Iwase N, Matsuoka M, Arakawa T, Nishida S, and Fushinobu S. Isolation and characterization of a thermostable lipase from Bacillus thermoamylovorans NB501. The Journal of General and Applied Microbiology 62(6):313-319
		14	Sugiyama Y, Nakamura A, Matsumoto M, Kanbe A, Sakanaka M, Higashi K, Igarashi K, Katayama T, Suzuki H, and Kurihara S. A novel putrescine exporter SapBCDF of Escherichia coli. Journal of Biological Chemistry 291(51):26343-26351
		13	Sakaguchi K, Katoh T, Yamamoto K. Transglycosidase-like activity of Mucor hiemalis endoglycosidase mutants enabling the synthesis of glycoconjugates using a natural glycan donor. Biotechnology and Applied Biochemistry 63(6):812-819
		12	Katoh T (corresponding author), Katayama T, Tomabechi Y, Nishikawa Y, Kumada J, Matsuzaki Y, Yamamoto K. Generation of a Mutant Mucor hiemalis Endoglycosidase that Acts on Core-fucosylated N-Glycans. Journal of Biological Chemistry 291(44):23305-23317
		11	Matsumura E, Nakagawa A, Tomabechi Y, Koyanagi T, Kumagai H, Yamamoto K, Katayama T, Sato F, and Minami H. Laboratory-scale production of (S)-reticuline, an important intermediate of benzylisoquinoline alkaloids, using a bacterial-based method. Bioscience, Biotechnology, and Biochemistry 14:1-7
		10	Sugiyama Y, Gotoh A, Katoh T, Honda Y, Yoshida E, Kurihara S, Ashida H, Kumagai H, Yamamoto K, Kitaoka M, and Katayama T (corresponding author). Introduction of H-antigens into oligosaccharides and sugar chains of glycoproteins using highly efficient 1,2-α-L-fucosynthase. Glycobiology 26(11):1235-1247
		9	Katayama-Ikegami A, Katayama T, Takai M, and Sakamoto T. Reference gene validation for gene expression studies using quantitative RT-PCR during berry development of ‘Aki Queen’ grapes. VITIS: Journal of Grapevine Research 55:157-160
		8	Katayama-Ikegami A, Sakamoto T, Shibuya K, Katayama T, and Gao-Takai M. Effects of abscisic acid treatment on berry coloration and expression of flavonoid biosynthesis genes in grape. American Journal of Plant Sciences 7:1325-1336
		7	Sakanaka M, Sugiyama Y, Kitakata A, Katayama T, and Kurihara S. Carboxyspermidine decarboxylase of the prominent intestinal microbiota species Bacteroides thetaiotaomicron is required for spermidine biosynthesis and contributes to normal growth. Amino Acids 48:2443-2451
		6	Barla F, Koyanagi T, Tokuda N, Matsui H, Katayama T, Kumagai H, Michihata T, Sasaki T, Tsuji A, and Enomoto T. The γ-aminobutyric acid-producing ability under low pH conditions of lactic acid bacteria isolated from traditional fermented foods of Ishikawa Prefecture, Japan, with a strong ability to produce ACE-inhibitory peptides. Biotechnology Reports 10:105-110.
		5	Ishida R, Sakaguchi K, Matsuzaki C, Katoh T, Ishida N, Yamamoto K, and Hisa K. Levansucrase from Leuconostoc mesenteroides NTM048 Produces a Levan Exopolysaccharide with Immunomodulating Activity. Biotechnology Letters 38(4):681-7.
		4	Matsuzaki C, Matsumoto K, Katoh T, Yamamoto K, Hisa K. Comparison of the activity to stimulate mucosal IgA production between Leuconostoc mesenteroides strain NTM048 and type strain JCM6124 in mice. Biosci. Microbiota Food Health 35(1):51-5
		3	Nakagawa A, Matsumura E, Koyanagi T, Katayama T, Kawano N, Yoshimatsu K, Yamamoto K, Kumagai H, Sato F, Minami H. Total biosynthesis of opiates by stepwise fermentation using engineered Escherichia coli. Nature Communications 7:10390
		2	Hidaka M, Gotoh A (equal contribution), Shimizu T, Minamisawa K, Imamura H, Uchida T. Visualization of NO₃⁻/NO₂⁻ Dynamics in Living cells by Fluorescence Resonance Energy Transfer (FRET) Imaging Employing a Rhizobial Two-Component Regulatory System. Journal of Biological Chemistry* 291(5):2260-2269 (Paper of the week)
		1	Koyanagi T, Nakagawa A, Kiyohara M, Matsui H, Tsuji A, Barla F, Take H, Katsuyama Y, Tokuda K, Nakamura S, Minami H, Enomoto T, Katayama T, and Kumagai H. Tracing microbiota changes in yamahai-moto, the traditional Japanese sake starter. Bioscience, Biotechnology, and Biochemistry 80(2):399-406
	総説	3	苫米地祐輔, 加藤紀彦, 山本憲二. 均一な糖鎖を持つバイオ医薬品の開発. Medical Science Digest 42(10):449-451.
		2	加藤紀彦. シグレックとムチン糖鎖の相互作用を介した炎症抑制機構~ムチン糖鎖のアレルギー性免疫応答における役割. 化学と生物 54(6):375-376.
		1	Katayama T. Host-derived glycans serve as selected nutrients for the gu t microbe: Human milk oligosaccharides and bifidobacteria. Bioscience, Biotechnology, and Biochemistry 80:621-632.

2015年

	原著論文	6	Hattie M, Ito T, Debowski AW, Arakawa T, Katayama T, Yamamoto K, Fushinobu S, and KA Stubbs. Gaining insight into the catalysis by GH20 lacto-N-biosidase using small molecule inhibitors and structural analysis. Chemical Communications 51(81):15008-11.
		5	Matsuzaki C, Hayakawa A, Matsumoto K, Katoh T, Yamamoto K, Hisa K. Exopolysaccharides Produced by Leuconostoc mesenteroides Strain NTM048 as an Immunostimulant to Enhance the Mucosal Barrier and Influence the Systemic Immune Response. Journal of Agricultural and Food Chemistry 63(31):7009-15.
		4	Gotoh A, Katoh T, Sugiyama Y, Kurihara S, Honda Y, Sakurama H, Kambe T, Ashida H, Kitaoka M, Yamamoto K, Katayama T (corresponding author). Novel substrate specificities of two lacto-N-biosidases towards β-linked galacto-N-biose-containing oligosaccharides of globo H, Gb5, and GA1. Carbohydrate Research 408:18-24.
		3	Dwyer C A, Katoh T, Michael Tiemeyer, and Russell T. Matthews. Neurons and glia modify RPTPζ/phosphacan with cell-specific O-mannosyl glycans in the developing brain. Journal of Biological Chemistry 290(16):10256-73.
		2	Kiwamoto T,Katoh T (equal contribution), Evans M C, Janssen J W, Brummet E M, Hudson A S, Zhu Z, Tiemeyer M, Bochner S B. Endogenous airway mucins carry glycans that bind Siglec-F and induce eosinophil apoptosis. Journal of Allergy and Clinical Immunology* 135(5): 1329-1340. e9.
		1	Shimada Y, Watanabe Y, Wakinaka T, Funeno Y, Kubota M, Chaiwangsri T, Kurihara S, Yamamoto K, Katayama T, Ashida H. α-N-Acetylglucosaminidase from Bifidobacterium bifidum specifically hydrolyzes α-linked N-acetylglucosamine at nonreducing terminus of O-glycan on gastric mucin. Applied Microbiology and Biotechnology 99(9):3941-8.
	総説	1	加藤紀彦、際本拓未. Siglec-Fとムチンの相互作用による好酸球炎症制御、THE LUNG perspectives 23(2):68-73.
	著書	1	Katoh T and Yamamoto K. Chapter 47, Glycoenzymes in Glycan Analysis and Synthesis. Glycoscience: Biology and Medicine (eds. by Taniguchi N, Endo T. Hart GW, Seeberger PH, Wong C.-H.). pp.379-389. Springer.

～2014年

→2014年までの研究業績

　京都大学大学院　生命科学研究科　統合生命科学専攻　応用生物機構学講座　分子応答機構学分野　片山グループ　

　Katayama group. Laboratory of Molecular Biology and Bioresponse, Graduate School of Biostudies, Kyoto University　